FDA Inspection 905182 — Attix Pharmaceuticals Inc.
The FDA completed an inspection of Attix Pharmaceuticals Inc. on November 14, 2014 in Toronto. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI) (OAI)
- End Date
- November 14, 2014
- Fiscal Year
- 2015
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Toronto (Canada)